While AUA does not yet explicitly mention GLP-1 agonists, the emerging evidence (below) suggests these agents could play a role in improving metabolic hypogonadism and should be considered in consultation with endocrinologists for obese men with fertility issues
Lets break it down together, step by step, to ensure you feel confident in managing your dosage
Most supportive claims come from BPC-157 animal studies or full thymosin beta-4 research
Sikiric, P., Drmic, D., Sever, M., Klicek, R., Blagaic, A., Tvrdei, A., Kralj, T., Kovac, K., Vukojevi, J., Siroglavi, M., Gojkovic, S., Krezic, I., Pavlov, K., Rasic, D., Mirkovic, I., Kokot, A., krti, A., & Seiwerth, S
CPT is a trademark of the AMA